Miniature swine were previously considered a non-rodent model for nonclinical dermal studies. Today, they are used for a number of therapeutic areas, including but not limited to metabolic diseases and inflammation.

Learn about the applications of miniature swine and the therapeutic areas they can support in this interview with Dr. Scott Boley, Senior VP of Research at Altasciences.

Watch Now

Dr. Scott Boley is attending the ACT Annual Meeting from November 13 to 16, stop by Booth #305 or pre-book a meeting to get in-touch. We hope to see you there!

Not attending ACT? Check out these webinars instead:  

• How Do I Select the Right Species for My Toxicology Program?
• Avoiding Obstacles When Outsourcing Your Nonclinical Research
• Miniature Swine Model Selection Criteria for Toxicology and Pharmacology Studies

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO.

CNS Center of Excellence

Are you working on a CNS-active drug? With over 25 years of conducting preclinical and clinical studies, Altasciences’ CNS Center of Excellence experts have developed an extensive resource library, including webinars and scientific journals, to guide you through all phases of early drug development, from lead candidate selection to clinical proof of concept, and beyond.